Litigation Details for Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. (D. Del. 2024)
✉ Email this page to a colleague
Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. (D. Del. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-05-13 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | None | Referred To | |
Patents | 10,105,323; 9,907,756 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc.
Details for Apotex Inc. v. Boehringer Ingelheim Pharmaceuticals, Inc. (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2024-05-13 | 5 | ANDA Form | Expiration of Patent: U.S. Patent No. 9,907,756 expires on 06/07/2029, U.S. Patent No. 10,105,323 expires on… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 13 May 2024 1:24-cv-00577 830 Patent None District Court, D. Delaware | External link to document |
2024-05-13 | 6 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756; 10,105,323. (mrr) (Entered… 13 May 2024 1:24-cv-00577 830 Patent None District Court, D. Delaware | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |